Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Longitudinal Study to Investigate the Effect of Thermal Injury on Intestinal Permeability and Systemic Inflammation (HESTIA)

NCT03242434 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT03242434
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03242434 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Longitudinal Study to Investigate the Effect of Thermal Injury on Intestinal Permeability and Systemic Inflammation (HESTIA)
Lead sponsor
GlaxoSmithKline
Phase
Phase 1
Overall status
Terminated
Start date
January 29, 2018
Completion date
March 26, 2018
Enrollment
18 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

burns